CVS Health to terminate SilverScript Choice PDP in 13 regions for 2027, affecting 950,000 enrollees

A Kaiser Family Foundation report indicates CVS Health will terminate its SilverScript Choice stand-alone prescription drug plan in 13 regions for 2027, affecting about 950,000 enrollees, or 81% of enrollees in terminated PDPs. Affected beneficiaries must select a new plan to maintain Medicare Part D coverage.

Detected & updated continuously · Source: Nebula